Regulus Therapeutics reported $25.3M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Alnylam Pharmaceuticals ALNY:US $ 17.65B 2.06B
AstraZeneca AZN:LN 16734.4B 1035.33B
Astrazeneca AZN:US 203.74B 2.44B
Biogen BIIB:US $ 29.87B 1.08B
Celldex Therapeutics CLDX:US $ 1.26B 0.33B
Gilead Sciences GILD:US $ 77.53B 2.87B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
Intrexon XON:US $ 0.28B 0.16B
Lexicon Pharmaceuticals LXRX:US $ 0.28B 0.04B
Ligand Pharmaceuticals LGND:US $ 1.5B 0.39B
Merk MRK:US $ 230.55B 23.1B
Omeros OMER:US $ 0.17B 0.2B
Regulus Therapeutics RGLS:US $ 0.03B 0.01B
Sangamo Biosciences SGMO:US $ 0.61B 0.24B
Sanofi SNY:US 127.77B 1.58B
Spectrum Pharmaceuticals SPPI:US $ 0.14B 0.09B
Takeda 4502:JP 6041.08B 506.36B
Vital Therapies VTL:US $ 0.08B 0.25B
YTE INCY:US $ 16.83B 0.75B